Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
48.99
-0.07 (-0.14%)
At close: Jul 30, 2026, 4:00 PM EDT
49.50
+0.51 (1.04%)
After-hours: Jul 30, 2026, 7:34 PM EDT
Scholar Rock Holding Employees
Scholar Rock Holding had 289 employees as of December 31, 2025. The number of employees increased by 93 or 47.45% compared to the previous year.
Employees
289
Change (1Y)
93
Growth (1Y)
47.45%
Revenue / Employee
n/a
Profits / Employee
-$1,414,277
Market Cap
5.87B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 289 | 93 | 47.45% |
| Dec 31, 2024 | 196 | 46 | 30.67% |
| Dec 31, 2023 | 150 | 36 | 31.58% |
| Dec 31, 2022 | 114 | -31 | -21.38% |
| Dec 31, 2021 | 145 | 26 | 21.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 418 |
| Xenon Pharmaceuticals | 370 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
SRRK News
- 1 day ago - Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference - Business Wire
- 10 days ago - Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 - Reuters
- 10 days ago - Scholar Rock provides update on timing of CHMP opinion for apitegromab MAA - TheFly
- 10 days ago - Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA) - Business Wire
- 13 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - Scholar Rock to Report Second Quarter 2026 Financial Results on August 6, 2026 - Business Wire
- 5 weeks ago - Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD - Business Wire
- 7 weeks ago - Scholar Rock Holding Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts